Castle Biosciences, Inc. (CSTL) — Stock Score Summary

Castle Biosciences, Inc. (CSTL) has a MoatMap StockRank of 32/100 based on Quality (56/100), Value (50/100), and Momentum (13/100) factor scores. The current signal is HOLD.

Castle Biosciences, Inc. is a commercial-stage dermatological diagnostics company focused on improving patient care through its proprietary genomic tests for skin cancers. The company's tests provide actionable information to clinicians and patients to guide treatment decisions and predict recurrence risk for melanoma, cutaneous squamous cell carcinoma, and other dermatologic conditions. Castle Biosciences holds a niche leadership position by developing and commercializing clinically validated molecular diagnostics for challenging dermatologic cancers.

Key Financial Metrics

Price$22.11
Market Cap$671M
P/E (Forward)-21.85
Price/Book1.29
Return on Equity-2.8%
Return on Invested Capital-5.8%
Debt/Equity7.96
Gross Margin77.9%
Operating Margin-22.0%
Revenue Growth-4.9%
Free Cash Flow$13M

Castle Biosciences, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Castle Biosciences, Inc.’s (CSTL) StockRank?
MoatMap’s StockRank for Castle Biosciences, Inc. (CSTL) is 32/100, with a Hold signal. It is a composite of Quality (56), Value (50), and Momentum (13) factor ranks across MoatMap’s 19,000+ stock universe.
Does Castle Biosciences, Inc. have an economic moat?
Castle Biosciences, Inc. (CSTL) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Castle Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Castle Biosciences, Inc. (CSTL) is Hold, based on a StockRank of 32/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Castle Biosciences, Inc. in?
Castle Biosciences, Inc. (CSTL) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksCSTL deep dive reportAI ChampionsHow we score stocksSense-check another stock